Relmada Therapeutics Inc
(NAS:RLMD)
$
6.67
+0.24 (+3.72%)
Market Cap: 699.74 Mil
Enterprise Value: 468.40 Mil
PE Ratio: 0
PB Ratio: 3.20
GF Score: 29/100 Relmada Therapeutics Inc (RLMD) Transcripts
- 1